Screening and surveillance of multiple solid tumours using plasma placental-like chondroitin sulfate A (pl-CSA).
Conclusion: These data indicate a direct link between plasma pl-CSA content and tumour presence, indicating that plasma pl-CSA may be a non-invasive biomarker with clinical applicability for the screening and surveillance of patients with multiple types of solid tumours.
PMID: 32038099 [PubMed - in process]
Source: International Journal of Medical Sciences - Category: Biomedical Science Tags: Int J Med Sci Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Cervical Cancer | Esophagus Cancer | Lung Cancer | Ovarian Cancer | Ovaries